The combination of strong revenue growth, improved R&D efficiency, and maintained guidance suggests RYTELO is gaining commercial traction. Traders should monitor whether 2026 revenue growth accelerates within the guided range and whether cost discipline offsets the cash burn.
Price Chart
Executive Summary
Geron Corporation reported strong full-year 2025 financial results with RYTELO net product revenue of $183.6 million, up from $76.5 million in 2024, representing significant year-over-year growth. The company reiterated 2026 revenue guidance of $220–240 million and expects lower operating expenses despite a one-time $17 million restructuring charge in Q4 2025.
Key Financial Metrics
Key Facts
- RYTELO net product revenue was $183.6 million in full-year 2025, up from $76.5 million in 2024 (139.9% YoY growth)
- Q4 2025 revenue was $48.0 million, with demand growing 9% QoQ
- Company reiterated 2026 RYTELO net product revenue guidance of $220–240 million
- Total operating expenses for 2025 were $254.7 million, within prior guidance
- Restructuring charge of $17.0 million in Q4 2025 due to workforce reduction (~1/3 of staff)
- Ended 2025 with $401.1 million in cash, down from $502.9 million in 2024
- R&D expenses decreased to $73.7 million in 2025 from $103.7 million in 2024
Financial Impact
Revenue grew 140% YoY to $183.6M in 2025 with strong Q4 momentum; 2026 revenue guidance implies 19-20% growth at midpoint
Segment Breakdown
| Segment | Revenue | Growth |
|---|---|---|
| RYTELO (imetelstat) | $183.6M | +139.9% |
Risk Factors
- Cash position decreased by ~$100 million year-over-year, raising questions about sustainability if revenue growth slows
- Restructuring may impact execution, especially with one-third of workforce reduced
- Forward guidance is flat to prior year's growth rate despite strong 2025 performance, suggesting potential deceleration
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-068523 |
| Document: d67820d8k.htm | 0001193125-26-068523 |
| Document: 0001193125-26-068523-index-headers.html | 0001193125-26-068523 |
| Document: 0001193125-26-068523-index.html | 0001193125-26-068523 |
| Document: 0001193125-26-068523.txt | 0001193125-26-068523 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Apr 22, 2026 23w ago | Press Release | $1.55 $1.44 | ▼ −7.10% | ▼ −11.88% | $1.21 (−21.94%) |
Apr 7, 2026 25w ago | DEFA14A | $1.71 $1.36 | ▼ −20.47% | ▼ −30.92% | $1.21 (−29.24%) |
Mar 30, 2026 26w ago | Court Ruling | $1.41 $1.37 | ▼ −2.84% | ▼ −19.33% | $1.21 (−14.18%) |
Feb 25, 2026 31w ago | 8-K | $1.72 $1.26 | ▼ −26.74% | ▼ −33.69% | $1.21 (−29.65%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access